| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cargo receptor activity | 6.14e-06 | 85 | 9 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | calcium ion binding | 8.14e-06 | 749 | 9 | 5 | GO:0005509 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.16e-05 | 16 | 9 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.78e-05 | 21 | 9 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 6.30e-05 | 27 | 9 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 1.33e-04 | 39 | 9 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.28e-04 | 323 | 9 | 3 | GO:1901681 | |
| GeneOntologyMolecularFunction | integrin binding | 2.64e-03 | 175 | 9 | 2 | GO:0005178 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 3.67e-03 | 207 | 9 | 2 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 3.85e-03 | 212 | 9 | 2 | GO:0017171 | |
| GeneOntologyMolecularFunction | amide binding | 7.51e-03 | 299 | 9 | 2 | GO:0033218 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.69e-06 | 5 | 9 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.69e-06 | 5 | 9 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.55e-06 | 7 | 9 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.11e-05 | 12 | 9 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.54e-05 | 14 | 9 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 4.65e-05 | 24 | 9 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 4.65e-05 | 24 | 9 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | negative regulation of cytosolic calcium ion concentration | 5.05e-05 | 25 | 9 | 2 | GO:0051481 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 6.36e-05 | 28 | 9 | 2 | GO:0042953 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 6.36e-05 | 28 | 9 | 2 | GO:0007039 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 6.83e-05 | 29 | 9 | 2 | GO:0044872 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 8.59e-05 | 212 | 9 | 3 | GO:0003205 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.33e-05 | 218 | 9 | 3 | GO:0090101 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 1.31e-04 | 40 | 9 | 2 | GO:0097242 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.65e-04 | 1442 | 9 | 5 | GO:0072359 | |
| GeneOntologyBiologicalProcess | heart development | 1.96e-04 | 757 | 9 | 4 | GO:0007507 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue morphogenesis | 2.86e-04 | 59 | 9 | 2 | GO:0055010 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.68e-04 | 347 | 9 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 4.62e-04 | 75 | 9 | 2 | GO:0050918 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 4.74e-04 | 76 | 9 | 2 | GO:0003229 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue morphogenesis | 4.87e-04 | 77 | 9 | 2 | GO:0055008 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 5.25e-04 | 80 | 9 | 2 | GO:0030514 | |
| GeneOntologyBiologicalProcess | aorta development | 5.25e-04 | 80 | 9 | 2 | GO:0035904 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 5.65e-04 | 83 | 9 | 2 | GO:0060976 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 6.08e-04 | 412 | 9 | 3 | GO:0090287 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 6.21e-04 | 87 | 9 | 2 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 6.35e-04 | 88 | 9 | 2 | GO:0010232 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 6.35e-04 | 88 | 9 | 2 | GO:0003208 | |
| GeneOntologyBiologicalProcess | amide transport | 6.43e-04 | 420 | 9 | 3 | GO:0042886 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 6.50e-04 | 89 | 9 | 2 | GO:0001523 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 6.79e-04 | 91 | 9 | 2 | GO:0033627 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 6.94e-04 | 92 | 9 | 2 | GO:0048844 | |
| GeneOntologyBiologicalProcess | muscle tissue morphogenesis | 7.09e-04 | 93 | 9 | 2 | GO:0060415 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 7.25e-04 | 94 | 9 | 2 | GO:0016101 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 7.61e-04 | 445 | 9 | 3 | GO:0141091 | |
| GeneOntologyBiologicalProcess | muscle organ morphogenesis | 8.52e-04 | 102 | 9 | 2 | GO:0048644 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 9.03e-04 | 105 | 9 | 2 | GO:0006721 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 9.59e-04 | 482 | 9 | 3 | GO:0007178 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.40e-03 | 131 | 9 | 2 | GO:0030510 | |
| GeneOntologyBiologicalProcess | artery development | 1.44e-03 | 133 | 9 | 2 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.46e-03 | 134 | 9 | 2 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of protein transport | 1.48e-03 | 560 | 9 | 3 | GO:0051223 | |
| GeneOntologyBiologicalProcess | negative regulation of transforming growth factor beta receptor signaling pathway | 1.55e-03 | 138 | 9 | 2 | GO:0030512 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.69e-03 | 144 | 9 | 2 | GO:0006720 | |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 1.83e-03 | 150 | 9 | 2 | GO:0090288 | |
| GeneOntologyBiologicalProcess | negative regulation of catalytic activity | 1.94e-03 | 615 | 9 | 3 | GO:0043086 | |
| GeneOntologyBiologicalProcess | tube development | 2.03e-03 | 1402 | 9 | 4 | GO:0035295 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 2.10e-03 | 161 | 9 | 2 | GO:0003206 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 2.10e-03 | 161 | 9 | 2 | GO:0003231 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | 2.52e-03 | 674 | 9 | 3 | GO:0070201 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 2.97e-03 | 192 | 9 | 2 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 3.06e-03 | 195 | 9 | 2 | GO:1903844 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 3.13e-03 | 197 | 9 | 2 | GO:0030509 | |
| GeneOntologyBiologicalProcess | circulatory system process | 3.20e-03 | 733 | 9 | 3 | GO:0003013 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 3.44e-03 | 752 | 9 | 3 | GO:1901699 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.62e-04 | 45 | 9 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 5.12e-04 | 80 | 9 | 2 | GO:0005905 | |
| MousePheno | increased heart left ventricle size | 6.94e-05 | 134 | 9 | 3 | MP:0010579 | |
| MousePheno | abnormal heart right ventricle morphology | 1.09e-04 | 156 | 9 | 3 | MP:0003920 | |
| MousePheno | abnormal heart left ventricle size | 1.38e-04 | 169 | 9 | 3 | MP:0010578 | |
| MousePheno | diaphragmatic hernia | 1.48e-04 | 29 | 9 | 2 | MP:0003924 | |
| MousePheno | increased heart ventricle size | 1.53e-04 | 175 | 9 | 3 | MP:0008772 | |
| MousePheno | cardiac hypertrophy | 2.14e-04 | 196 | 9 | 3 | MP:0001625 | |
| MousePheno | overexpanded pulmonary alveolus | 2.43e-04 | 37 | 9 | 2 | MP:0001183 | |
| MousePheno | emphysema | 2.43e-04 | 37 | 9 | 2 | MP:0001958 | |
| MousePheno | decreased survivor rate | 2.81e-04 | 215 | 9 | 3 | MP:0008770 | |
| MousePheno | heart right ventricle hypertrophy | 3.13e-04 | 42 | 9 | 2 | MP:0000276 | |
| MousePheno | abnormal heart ventricle size | 3.35e-04 | 228 | 9 | 3 | MP:0031543 | |
| MousePheno | abnormal heart right ventricle wall morphology | 4.81e-04 | 52 | 9 | 2 | MP:0031534 | |
| MousePheno | lethality, incomplete penetrance | 4.81e-04 | 258 | 9 | 3 | MP:0010831 | |
| MousePheno | omphalocele | 4.99e-04 | 53 | 9 | 2 | MP:0003052 | |
| MousePheno | increased heart right ventricle size | 5.38e-04 | 55 | 9 | 2 | MP:0010563 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | 5.64e-04 | 1269 | 9 | 5 | MP:0011111 | |
| MousePheno | abnormal heart ventricle wall morphology | 7.18e-04 | 296 | 9 | 3 | MP:0031532 | |
| MousePheno | heart left ventricle hypertrophy | 7.50e-04 | 65 | 9 | 2 | MP:0002625 | |
| MousePheno | abnormal heart ventricle morphology | 1.03e-03 | 793 | 9 | 4 | MP:0005294 | |
| MousePheno | abnormal diaphragm morphology | 1.08e-03 | 78 | 9 | 2 | MP:0002279 | |
| MousePheno | abnormal heart right ventricle size | 1.08e-03 | 78 | 9 | 2 | MP:0010577 | |
| MousePheno | abnormal abdominal wall morphology | 1.19e-03 | 82 | 9 | 2 | MP:0003257 | |
| MousePheno | abnormal heart left ventricle morphology | 1.36e-03 | 369 | 9 | 3 | MP:0003921 | |
| MousePheno | abnormal heart electrocardiography waveform feature | 1.45e-03 | 377 | 9 | 3 | MP:0010508 | |
| MousePheno | abnormal heart septum morphology | 1.57e-03 | 388 | 9 | 3 | MP:0006113 | |
| MousePheno | abnormal impulse conducting system conduction | 1.72e-03 | 400 | 9 | 3 | MP:0003137 | |
| MousePheno | abnormal heart left ventricle wall morphology | 1.73e-03 | 99 | 9 | 2 | MP:0031533 | |
| MousePheno | enlarged heart | 1.77e-03 | 916 | 9 | 4 | MP:0000274 | |
| MousePheno | lethality throughout fetal growth and development | 2.19e-03 | 435 | 9 | 3 | MP:0006208 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 3.05e-03 | 489 | 9 | 3 | MP:0010630 | |
| MousePheno | abnormal thoracic aorta morphology | 3.14e-03 | 134 | 9 | 2 | MP:0010468 | |
| MousePheno | abnormal hypaxial muscle morphology | 3.47e-03 | 141 | 9 | 2 | MP:0003358 | |
| MousePheno | abnormal muscle morphology | 3.55e-03 | 1106 | 9 | 4 | MP:0002108 | |
| MousePheno | cardiac fibrosis | 3.97e-03 | 151 | 9 | 2 | MP:0003141 | |
| MousePheno | abnormal body wall morphology | 3.97e-03 | 151 | 9 | 2 | MP:0003385 | |
| MousePheno | abnormal heart size | 4.50e-03 | 1180 | 9 | 4 | MP:0005406 | |
| MousePheno | decreased respiration | 5.00e-03 | 170 | 9 | 2 | MP:0014274 | |
| Domain | EGF-like_dom | 4.88e-08 | 249 | 9 | 5 | IPR000742 | |
| Domain | EGF_CA | 5.19e-08 | 86 | 9 | 4 | PF07645 | |
| Domain | EGF_1 | 5.50e-08 | 255 | 9 | 5 | PS00022 | |
| Domain | EGF_2 | 6.66e-08 | 265 | 9 | 5 | PS01186 | |
| Domain | EGF_Ca-bd_CS | 8.44e-08 | 97 | 9 | 4 | IPR018097 | |
| Domain | EGF_CA | 9.17e-08 | 99 | 9 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.55e-08 | 100 | 9 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.21e-07 | 106 | 9 | 4 | IPR000152 | |
| Domain | cEGF | 2.00e-07 | 26 | 9 | 3 | PF12662 | |
| Domain | cEGF | 2.00e-07 | 26 | 9 | 3 | IPR026823 | |
| Domain | EGF_CA | 2.13e-07 | 122 | 9 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.27e-07 | 124 | 9 | 4 | IPR001881 | |
| Domain | EGF | 2.93e-06 | 235 | 9 | 4 | SM00181 | |
| Domain | EGF_3 | 2.93e-06 | 235 | 9 | 4 | PS50026 | |
| Domain | EGF-like_CS | 4.44e-06 | 261 | 9 | 4 | IPR013032 | |
| Domain | Ldl_recept_b | 1.87e-05 | 14 | 9 | 2 | PF00058 | |
| Domain | LDLRB | 1.87e-05 | 14 | 9 | 2 | PS51120 | |
| Domain | LY | 2.16e-05 | 15 | 9 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.16e-05 | 15 | 9 | 2 | IPR000033 | |
| Domain | Growth_fac_rcpt_ | 4.63e-05 | 156 | 9 | 3 | IPR009030 | |
| Domain | - | 1.52e-04 | 39 | 9 | 2 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.59e-04 | 40 | 9 | 2 | IPR023415 | |
| Domain | Ldl_recept_a | 2.02e-04 | 45 | 9 | 2 | PF00057 | |
| Domain | - | 2.11e-04 | 46 | 9 | 2 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.11e-04 | 46 | 9 | 2 | IPR011042 | |
| Domain | LDLRA_1 | 2.30e-04 | 48 | 9 | 2 | PS01209 | |
| Domain | LDLa | 2.40e-04 | 49 | 9 | 2 | SM00192 | |
| Domain | LDLRA_2 | 2.40e-04 | 49 | 9 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 2.40e-04 | 49 | 9 | 2 | IPR002172 | |
| Domain | EGF_extracell | 3.60e-04 | 60 | 9 | 2 | IPR013111 | |
| Domain | EGF_2 | 3.60e-04 | 60 | 9 | 2 | PF07974 | |
| Domain | EGF | 1.58e-03 | 126 | 9 | 2 | PF00008 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.54e-04 | 45 | 9 | 2 | MM15344 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.03e-04 | 48 | 9 | 2 | M27642 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 6.29e-04 | 60 | 9 | 2 | MM14872 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.46e-03 | 381 | 9 | 3 | M48063 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.47e-03 | 92 | 9 | 2 | MM14881 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.60e-03 | 96 | 9 | 2 | M39581 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.67e-03 | 98 | 9 | 2 | M27152 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.74e-03 | 100 | 9 | 2 | M27158 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 6.05e-03 | 189 | 9 | 2 | MM14772 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 6.11e-03 | 190 | 9 | 2 | MM15687 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 6.51e-03 | 645 | 9 | 3 | MM15232 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 6.62e-03 | 198 | 9 | 2 | M18311 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | 9.01e-03 | 725 | 9 | 3 | M27507 | |
| Pubmed | 5.95e-08 | 2 | 9 | 2 | 34445520 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 5.95e-08 | 2 | 9 | 2 | 24484584 | |
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 7775583 | ||
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 11421580 | ||
| Pubmed | 3.57e-07 | 4 | 9 | 2 | 12413896 | ||
| Pubmed | 5.95e-07 | 5 | 9 | 2 | 16101684 | ||
| Pubmed | 5.95e-07 | 5 | 9 | 2 | 19047013 | ||
| Pubmed | 5.95e-07 | 5 | 9 | 2 | 18685438 | ||
| Pubmed | 6.79e-07 | 71 | 9 | 3 | 33541421 | ||
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 9837937 | ||
| Pubmed | 8.92e-07 | 6 | 9 | 2 | 21054788 | ||
| Pubmed | 1.25e-06 | 7 | 9 | 2 | 12169628 | ||
| Pubmed | LDL receptor-related protein as a component of the midkine receptor. | 2.14e-06 | 9 | 9 | 2 | 10772929 | |
| Pubmed | 3.27e-06 | 11 | 9 | 2 | 24639464 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 5.41e-06 | 14 | 9 | 2 | 17389516 | |
| Pubmed | 5.41e-06 | 14 | 9 | 2 | 15082773 | ||
| Pubmed | 9.09e-06 | 18 | 9 | 2 | 10827173 | ||
| Pubmed | Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit. | 1.25e-05 | 21 | 9 | 2 | 28302382 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.25e-05 | 21 | 9 | 2 | 21337463 | |
| Pubmed | 6.12e-05 | 46 | 9 | 2 | 20301533 | ||
| Pubmed | 6.40e-05 | 47 | 9 | 2 | 11208732 | ||
| Pubmed | 7.84e-05 | 52 | 9 | 2 | 26590417 | ||
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 9.43e-05 | 57 | 9 | 2 | 23788249 | |
| Interaction | ZFP41 interactions | 1.78e-06 | 57 | 9 | 3 | int:ZFP41 | |
| Interaction | MAPK8IP2 interactions | 1.48e-05 | 115 | 9 | 3 | int:MAPK8IP2 | |
| Interaction | CUBN interactions | 1.86e-05 | 15 | 9 | 2 | int:CUBN | |
| Interaction | ZDHHC15 interactions | 1.90e-05 | 125 | 9 | 3 | int:ZDHHC15 | |
| Interaction | SCN3A interactions | 2.12e-05 | 16 | 9 | 2 | int:SCN3A | |
| Interaction | NTN5 interactions | 4.87e-05 | 24 | 9 | 2 | int:NTN5 | |
| Interaction | ITGB1BP1 interactions | 9.29e-05 | 33 | 9 | 2 | int:ITGB1BP1 | |
| Interaction | ANKS1B interactions | 9.87e-05 | 34 | 9 | 2 | int:ANKS1B | |
| Interaction | LPL interactions | 1.05e-04 | 35 | 9 | 2 | int:LPL | |
| Interaction | LDLRAP1 interactions | 1.17e-04 | 37 | 9 | 2 | int:LDLRAP1 | |
| Interaction | MBL2 interactions | 1.17e-04 | 37 | 9 | 2 | int:MBL2 | |
| Interaction | CCN2 interactions | 1.37e-04 | 40 | 9 | 2 | int:CCN2 | |
| Interaction | APBA2 interactions | 1.98e-04 | 48 | 9 | 2 | int:APBA2 | |
| Interaction | SERPINE1 interactions | 2.51e-04 | 54 | 9 | 2 | int:SERPINE1 | |
| Interaction | MAPK8IP1 interactions | 2.89e-04 | 58 | 9 | 2 | int:MAPK8IP1 | |
| Interaction | ANKRD36B interactions | 3.10e-04 | 60 | 9 | 2 | int:ANKRD36B | |
| Interaction | ANAPC10 interactions | 3.98e-04 | 68 | 9 | 2 | int:ANAPC10 | |
| Interaction | SNX17 interactions | 5.64e-04 | 81 | 9 | 2 | int:SNX17 | |
| Interaction | LRP1B interactions | 6.21e-04 | 85 | 9 | 2 | int:LRP1B | |
| Interaction | MDK interactions | 7.11e-04 | 91 | 9 | 2 | int:MDK | |
| Interaction | DAB1 interactions | 9.81e-04 | 107 | 9 | 2 | int:DAB1 | |
| Interaction | NOS1AP interactions | 1.09e-03 | 113 | 9 | 2 | int:NOS1AP | |
| Interaction | LAMA5 interactions | 1.17e-03 | 117 | 9 | 2 | int:LAMA5 | |
| Interaction | GIPC1 interactions | 1.21e-03 | 119 | 9 | 2 | int:GIPC1 | |
| Interaction | THBS1 interactions | 1.38e-03 | 127 | 9 | 2 | int:THBS1 | |
| Interaction | SYNJ2BP interactions | 1.47e-03 | 131 | 9 | 2 | int:SYNJ2BP | |
| Interaction | DAB2 interactions | 1.67e-03 | 140 | 9 | 2 | int:DAB2 | |
| Interaction | ZNF408 interactions | 1.79e-03 | 145 | 9 | 2 | int:ZNF408 | |
| Interaction | C3 interactions | 2.04e-03 | 155 | 9 | 2 | int:C3 | |
| Interaction | GRIN2B interactions | 2.45e-03 | 170 | 9 | 2 | int:GRIN2B | |
| Interaction | APOE interactions | 2.48e-03 | 171 | 9 | 2 | int:APOE | |
| Interaction | LRPAP1 interactions | 2.74e-03 | 180 | 9 | 2 | int:LRPAP1 | |
| Interaction | APBB1 interactions | 3.21e-03 | 195 | 9 | 2 | int:APBB1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.92e-03 | 423 | 9 | 2 | chr12q13 | |
| GeneFamily | Low density lipoprotein receptors | 1.00e-05 | 13 | 7 | 2 | 634 | |
| GeneFamily | Proteases, serine | 2.48e-04 | 63 | 7 | 2 | 738 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE | 4.98e-07 | 211 | 9 | 4 | MM17081 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.25e-05 | 194 | 9 | 3 | M39122 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 7.84e-05 | 261 | 9 | 3 | M1834 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 2.09e-04 | 64 | 9 | 2 | M2572 | |
| Coexpression | REN_ALVEOLAR_RHABDOMYOSARCOMA_DN | 2.91e-04 | 407 | 9 | 3 | M19541 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 3.03e-04 | 77 | 9 | 2 | M19128 | |
| Coexpression | WONG_ENDMETRIUM_CANCER_DN | 3.10e-04 | 78 | 9 | 2 | M1311 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 3.64e-04 | 439 | 9 | 3 | M39054 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 4.22e-04 | 91 | 9 | 2 | M40180 | |
| Coexpression | CAHOY_ASTROGLIAL | 5.10e-04 | 100 | 9 | 2 | M2807 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 1.57e-05 | 408 | 9 | 4 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.36e-04 | 42 | 9 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | 1.94e-04 | 778 | 9 | 4 | gudmap_kidney_adult_RenalCapsule_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 2.26e-04 | 54 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.31e-04 | 814 | 9 | 4 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 3.46e-04 | 904 | 9 | 4 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 3.67e-04 | 357 | 9 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 3.79e-04 | 361 | 9 | 3 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 3.89e-04 | 364 | 9 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.05e-04 | 369 | 9 | 3 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 4.11e-04 | 371 | 9 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 4.14e-04 | 372 | 9 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.20e-04 | 951 | 9 | 4 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 4.58e-04 | 385 | 9 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 4.69e-04 | 388 | 9 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 4.73e-04 | 981 | 9 | 4 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 4.90e-04 | 990 | 9 | 4 | JC_fibro_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 5.21e-04 | 82 | 9 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.86e-04 | 87 | 9 | 2 | GSM777050_100 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | 6.11e-04 | 1049 | 9 | 4 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.63e-04 | 437 | 9 | 3 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 7.28e-04 | 97 | 9 | 2 | GSM777046_100 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.89e-04 | 464 | 9 | 3 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_500 | 9.47e-04 | 494 | 9 | 3 | JC_fibro_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 1.15e-03 | 122 | 9 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.20e-03 | 125 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.30e-03 | 130 | 9 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.64e-03 | 146 | 9 | 2 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.64e-03 | 146 | 9 | 2 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.66e-03 | 147 | 9 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 1.80e-03 | 153 | 9 | 2 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.87e-03 | 156 | 9 | 2 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-08 | 181 | 9 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.07e-08 | 193 | 9 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-08 | 195 | 9 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-08 | 195 | 9 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-08 | 198 | 9 | 4 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.69e-08 | 200 | 9 | 4 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.69e-08 | 200 | 9 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-06 | 168 | 9 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 169 | 9 | 3 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 169 | 9 | 3 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 169 | 9 | 3 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-06 | 171 | 9 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-06 | 172 | 9 | 3 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.61e-06 | 173 | 9 | 3 | b23b408acc29a667cce104429afef1a6cf2720a5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 175 | 9 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-06 | 175 | 9 | 3 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-06 | 176 | 9 | 3 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.86e-06 | 176 | 9 | 3 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.86e-06 | 176 | 9 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.86e-06 | 176 | 9 | 3 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.86e-06 | 176 | 9 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.03e-06 | 178 | 9 | 3 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-06 | 180 | 9 | 3 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-06 | 180 | 9 | 3 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.20e-06 | 180 | 9 | 3 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.28e-06 | 181 | 9 | 3 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.28e-06 | 181 | 9 | 3 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.28e-06 | 181 | 9 | 3 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.37e-06 | 182 | 9 | 3 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-06 | 182 | 9 | 3 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 183 | 9 | 3 | 7e5c467fd1b156b928f1611a12ab4affb9f714b7 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-06 | 183 | 9 | 3 | 63294d66e3ccf152ffe5d1237106764c14390b62 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.55e-06 | 184 | 9 | 3 | 01257e5c12e38b849fd3d9496c43ded666249ba5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.55e-06 | 184 | 9 | 3 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 185 | 9 | 3 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 185 | 9 | 3 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 186 | 9 | 3 | d998c5b00083cf2a7cd5341a98b7374b4de73c63 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 186 | 9 | 3 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 186 | 9 | 3 | 35c88cc4eb388811fcac4323b549e5897fa8dc27 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-06 | 186 | 9 | 3 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.73e-06 | 186 | 9 | 3 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 187 | 9 | 3 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 187 | 9 | 3 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 5.83e-06 | 187 | 9 | 3 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 187 | 9 | 3 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 5.83e-06 | 187 | 9 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-06 | 187 | 9 | 3 | 2c145e9d11424939dd99012a8cedf5d998b966e9 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 5.83e-06 | 187 | 9 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-06 | 188 | 9 | 3 | c32d023a69b6da79687ff8fa7485e7499db57046 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-06 | 188 | 9 | 3 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-06 | 188 | 9 | 3 | 1cd5a4d744bd3777246958ea5eb94388a5cbad81 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.02e-06 | 189 | 9 | 3 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.02e-06 | 189 | 9 | 3 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 6.11e-06 | 190 | 9 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 190 | 9 | 3 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 190 | 9 | 3 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 190 | 9 | 3 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 191 | 9 | 3 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 191 | 9 | 3 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 191 | 9 | 3 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 191 | 9 | 3 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.21e-06 | 191 | 9 | 3 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.21e-06 | 191 | 9 | 3 | 2b73fcd592d16cae8ded5e45c8fbf2d9adc8caad | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 191 | 9 | 3 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-06 | 191 | 9 | 3 | 1b26056df078674f37a6c06f6256b30cfcec21a7 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.21e-06 | 191 | 9 | 3 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.21e-06 | 191 | 9 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.21e-06 | 191 | 9 | 3 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-06 | 191 | 9 | 3 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-06 | 192 | 9 | 3 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.31e-06 | 192 | 9 | 3 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.31e-06 | 192 | 9 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-06 | 192 | 9 | 3 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-06 | 192 | 9 | 3 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.31e-06 | 192 | 9 | 3 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.31e-06 | 192 | 9 | 3 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-06 | 192 | 9 | 3 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.31e-06 | 192 | 9 | 3 | 011634a24b0c61d9b463fe755502edbc5cd70b7a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | 853a930e0641ffb50cbb4cef5837c70d75c3fc39 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | d2c03490c5e835d0f0a732803093c64b8d4b4029 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-06 | 192 | 9 | 3 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.31e-06 | 192 | 9 | 3 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | 49281626ecad0456fdbded2378b7028d7b589686 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.31e-06 | 192 | 9 | 3 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.31e-06 | 192 | 9 | 3 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-06 | 192 | 9 | 3 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.31e-06 | 192 | 9 | 3 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.31e-06 | 192 | 9 | 3 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.39e-04 | 50 | 7 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Drug | coprogen | 4.99e-06 | 9 | 9 | 2 | CID006323272 | |
| Drug | 25-azacoprostane | 6.24e-06 | 10 | 9 | 2 | CID000162243 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 4.35e-05 | 186 | 9 | 3 | 4463_UP | |
| Drug | Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 5.00e-05 | 195 | 9 | 3 | 6039_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 5.16e-05 | 197 | 9 | 3 | 4758_UP | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 5.24e-05 | 198 | 9 | 3 | 4706_UP | |
| Drug | Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; HL60; HT_HG-U133A | 5.39e-05 | 200 | 9 | 3 | 2987_UP | |
| Drug | tetrahydroaldosterone-3-glucuronide | 5.61e-05 | 29 | 9 | 2 | CID000167918 | |
| Drug | monatepil | 5.61e-05 | 29 | 9 | 2 | CID000060810 | |
| Drug | uPA inhibitor | 6.85e-05 | 32 | 9 | 2 | CID000001746 | |
| Drug | LMWH | 7.99e-05 | 663 | 9 | 4 | CID000000772 | |
| Drug | chloroquine | 1.59e-04 | 288 | 9 | 3 | CID000002719 | |
| Drug | AC1L2AC7 | 3.21e-04 | 69 | 9 | 2 | CID000068733 | |
| Drug | C4 m | 4.21e-04 | 79 | 9 | 2 | CID009543487 | |
| Drug | Ovalbumin | 4.54e-04 | 82 | 9 | 2 | ctd:D010047 | |
| Drug | Thalidomide | 7.07e-04 | 479 | 9 | 3 | ctd:D013792 | |
| Drug | clioquinol | 8.74e-04 | 114 | 9 | 2 | CID000002788 | |
| Drug | pitavastatin | 8.74e-04 | 114 | 9 | 2 | CID005282451 | |
| Drug | Simvastatin | 1.24e-03 | 581 | 9 | 3 | ctd:D019821 | |
| Drug | ezetimibe | 1.45e-03 | 147 | 9 | 2 | CID000150311 | |
| Drug | MW 1 | 1.53e-03 | 151 | 9 | 2 | CID000073965 | |
| Drug | CHAPS detergent | 1.67e-03 | 158 | 9 | 2 | CID000107670 | |
| Drug | 25-hydroxycholesterol | 1.71e-03 | 160 | 9 | 2 | CID000065094 | |
| Drug | probucol | 1.75e-03 | 162 | 9 | 2 | CID000004912 | |
| Drug | MF I | 1.77e-03 | 163 | 9 | 2 | CID000007871 | |
| Drug | dimethyloxalylglycine; Up 200; 1000uM; PC3; HG-U133A | 1.97e-03 | 172 | 9 | 2 | 584_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; HL60; HT_HG-U133A | 2.04e-03 | 175 | 9 | 2 | 2507_UP | |
| Drug | butenal | 2.16e-03 | 180 | 9 | 2 | CID000020138 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4442_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 4969_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 6498_UP | |
| Drug | 0175029-0000 [211245-78-2]; Up 200; 10uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 6875_UP | |
| Drug | indomethacin, USP; Up 200; 100uM; PC3; HG-U133A | 2.45e-03 | 192 | 9 | 2 | 452_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4650_DN | |
| Drug | Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 6809_UP | |
| Drug | Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 5077_UP | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 2998_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 2485_DN | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 2789_UP | |
| Drug | Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 5448_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1805_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Up 200; 17uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4538_UP | |
| Drug | Fluspirilen [1841-19-6]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6662_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6654_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4991_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2168_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4399_DN | |
| Drug | 17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6172_UP | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4676_DN | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 5399_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4250_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 5416_DN | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2538_UP | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; PC3; HG-U133A | 2.53e-03 | 195 | 9 | 2 | 434_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2241_DN | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3025_UP | |
| Drug | Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3171_UP | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6673_DN | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2393_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2198_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3742_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5084_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 7470_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4644_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5523_DN | |
| Disease | aortic measurement | 3.48e-07 | 251 | 8 | 4 | EFO_0020865 | |
| Disease | descending aortic diameter | 1.42e-06 | 88 | 8 | 3 | EFO_0021788 | |
| Disease | aortic aneurysm | 2.89e-06 | 10 | 8 | 2 | EFO_0001666 | |
| Disease | ascending aortic diameter | 5.75e-06 | 140 | 8 | 3 | EFO_0021787 | |
| Disease | spontaneous coronary artery dissection | 2.98e-05 | 31 | 8 | 2 | EFO_0010820 | |
| Disease | heart disease (implicated_via_orthology) | 4.50e-05 | 38 | 8 | 2 | DOID:114 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, systolic blood pressure | 5.99e-04 | 670 | 8 | 3 | EFO_0006335, EFO_0006336 | |
| Disease | Craniofacial Abnormalities | 7.62e-04 | 156 | 8 | 2 | C0376634 | |
| Disease | attempted suicide | 9.89e-04 | 178 | 8 | 2 | EFO_0004321 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EHGDDSCVHHCEDKE | 496 | Q9H3C7 | |
| SCVHHCEDKEDDGDS | 501 | Q9H3C7 | |
| DKEDDCEHGEDETHC | 2716 | Q07954 | |
| CEDYEHLCTEDHKES | 51 | P21128 | |
| VDDCGDGTDETEEHC | 3906 | P98164 | |
| ESDEEEEEGCGHTHC | 76 | O60927 | |
| KDEDECEEGKHDCTE | 2246 | P35555 | |
| DECKEREDEELSCDH | 141 | P48740 | |
| AKSCHDEEDDDGEEE | 3696 | Q92736 | |
| EFCDCDDRDCDKHDG | 446 | O95965 |